This inventor holds 2 USPTO granted patents. Top assignees: Instant Medical Diagnostics, LLC, Other. Active years: 2012-2014.
Company Filing History:
1 out of 4 
1 out of 834,307 Years Active: 2012-2014
Title: Gordon Whiteley: Innovator in Hepatitis C Detection
Introduction
Gordon Whiteley is a notable inventor based in Potomac, MD (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of hepatitis C virus (HCV) antibodies. With a total of 2 patents, his work has the potential to improve patient outcomes through innovative testing methods.
Latest Patents
One of Whiteley's latest patents is an oral fluid rapid assay for hepatitis C virus (HCV) antibodies. This method introduces a non-antibody detection molecule that labels all classes of patient antibodies in oral fluid. The process involves the specific concentration of labeled anti-HCV antibodies by selective capture in a trapping zone consisting of peptide antigens derived from the HCV genome. The signal generated by the labeled antibodies present in the trapping zone is proportional to the number of anti-HCV antibodies bound to the antigens. The presence of this signal indicates past exposure to HCV, providing a valuable tool for diagnosis.
Career Highlights
Throughout his career, Gordon Whiteley has worked with Instant Medical Diagnostics, LLC, where he has contributed to the development of innovative diagnostic solutions. His expertise in medical diagnostics has positioned him as a key player in the field.
Collaborations
Whiteley has collaborated with notable professionals such as Jonathan Zmuda and Lance A Liotta. These partnerships have further enhanced his work and contributed to advancements in hepatitis C detection.
Conclusion
Gordon Whiteley's innovative approach to hepatitis C detection through oral fluid assays exemplifies the impact of his work in medical diagnostics. His contributions continue to pave the way for improved testing methods and patient care.